1. American College of Rheumatology. Omega-3 and omega-6 fatty acid intake may affect lupus outcomes. November 4, 2017. Accessed January 25, 2018.2. US Food and Drug Administration. Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS): July - September 2017. Accessed January 25, 2018.3. Hesselstrand R, Nagel J, Saxne T, et al. Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis. Rheumatology. 2018 Jan 8. doi: 10.1093/rheumatology/kex471.4. Pfizer. Pfizer Announces FDA Approval of XELJANZÂ® (tofacitinib) and XELJANZÂ® XR for the Treatment of Active Psoriatic Arthritis. December 14, 2017.  Accessed January 25, 2018.5. Schwartz AM, Hinckley AF, Mead PS, et al. Surveillance for Lyme Disease - United States, 2008-2015. MMWR. 2017;66:1-12.  Accessed January 25, 2018.

Rheumatoid Arthritis

Lupus

Psoriatic Arthritis

Systemic Sclerosis

Highlights of 5 topline news stories from the FDA, CDC, and American College of Rheumatology-with real-world implications for primary care practice.